Rice Hall James & Associates LLC Takes $4.92 Million Position in Utah Medical Products, Inc. $UTMD

Rice Hall James & Associates LLC purchased a new stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 71,363 shares of the medical instruments supplier’s stock, valued at approximately $4,923,000.

Several other institutional investors and hedge funds also recently bought and sold shares of UTMD. Comerica Bank grew its stake in Utah Medical Products by 435.6% in the 3rd quarter. Comerica Bank now owns 541 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 440 shares in the last quarter. Fifth Third Bancorp purchased a new stake in shares of Utah Medical Products during the first quarter worth $43,000. BNP Paribas Financial Markets boosted its holdings in shares of Utah Medical Products by 89.6% in the third quarter. BNP Paribas Financial Markets now owns 1,060 shares of the medical instruments supplier’s stock worth $67,000 after acquiring an additional 501 shares during the period. State of Wyoming purchased a new position in shares of Utah Medical Products in the second quarter valued at $132,000. Finally, Russell Investments Group Ltd. grew its position in shares of Utah Medical Products by 550.5% in the second quarter. Russell Investments Group Ltd. now owns 2,758 shares of the medical instruments supplier’s stock valued at $157,000 after purchasing an additional 2,334 shares in the last quarter. 69.60% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised Utah Medical Products from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, August 12th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Utah Medical Products Trading Down 1.1%

UTMD stock opened at $70.21 on Tuesday. The firm has a 50 day moving average of $69.59 and a 200-day moving average of $66.62. The firm has a market capitalization of $223.55 million, a P/E ratio of 21.41 and a beta of 0.35. Utah Medical Products, Inc. has a 12 month low of $53.66 and a 12 month high of $75.75.

Utah Medical Products (NASDAQ:UTMD) last posted its earnings results on Thursday, July 23rd. The medical instruments supplier reported $0.84 earnings per share for the quarter. Utah Medical Products had a net margin of 29.04% and a return on equity of 8.74%. The business had revenue of $8.53 million for the quarter.

Utah Medical Products Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, October 5th. Stockholders of record on Thursday, September 17th will be issued a $0.31 dividend. The ex-dividend date of this dividend is Thursday, September 17th. This represents a $1.24 annualized dividend and a dividend yield of 1.8%. Utah Medical Products’s dividend payout ratio is presently 37.80%.

Utah Medical Products Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).